SCHEMBL4807374

SCHEMBL4807374

[CH]=CCCCC=C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5806296 0.94 KMT2A (0.40)
SCHEMBL11131196 0.85 KMT2A (0.50)
SCHEMBL6283056 0.82
SCHEMBL8078444 0.78 KMT2A (0.50)
SCHEMBL3498191 0.74
SCHEMBL9634269 0.74
SCHEMBL27816066 0.72 POLB (0.41)
SCHEMBL10885356 0.72
SCHEMBL43730 0.72
SCHEMBL1276454 0.71 KMT2A (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108440700-A The method for being used to prepare the copolymer of ethylene 维尔萨利斯股份公司 2018-08-24 CN claimed
CN-118355029-A Methods of treating diffuse large B-cell lymphomas using anti-CD 79B immunoconjugates 基因泰克公司 2024-07-16 CN disclosed
CN-112689634-B SMAD3 inhibitors 莫扎制药有限公司 2024-07-16 CN disclosed
CN-118302198-A Conjugates comprising phosphorus (V) and a camptothecin moiety TUBULIS 股份有限公司 2024-07-05 CN disclosed
CN-118302197-A Conjugates comprising phosphorus (V) and a drug moiety TUBULIS 股份有限公司 2024-07-05 CN disclosed
CN-113677364-B Pharmaceutical compositions comprising anti-191P 4D12 antibody drug conjugates and methods of use thereof 艾更斯司股份有限公司 2024-07-05 CN disclosed
CN-111569086-B Methylene carbamate linkers for use with target-drug conjugates 西雅图基因公司 2024-06-21 CN disclosed
CN-111558049-B Methylene carbamate linkers for use with target-drug conjugates 西雅图基因公司 2024-06-21 CN disclosed
CN-118201946-A Lipidated polymyxin analogues 奥克兰联合服务有限公司 2024-06-14 CN disclosed
US-20240190958-A1 NOVEL ANTIBODY DRUG CONJUGATES WITH NOVEL NAPI2B ANTIBODIES, THERAPEUTIC METHODS AND USES THEREOF TUBULIS GMBH (DE) 2024-06-13 US disclosed
WO-2018197963-A1 METHOD OF CYCLIC COMPOUNDS PRODUCTION IN OLEFINE METATHESIS REACTION AND USE OF RUTHENIUM CATALYSTS IN PRODUCTION OF CYCLIC OLEFINS IN OLEFINE METATHESIS REACTION UNIWERSYTET WARSZAWSKI (PL) 2018-11-01 WO disclosed
CN-108473707-A Foamed resin molded article and method for producing same 丰田纺织株式会社 2018-08-31 CN disclosed
CN-108440700-A The method for being used to prepare the copolymer of ethylene 维尔萨利斯股份公司 2018-08-24 CN disclosed
WO-2018100515-A1 NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS UNIWERSYTET WARSZAWSKI (PL) 2018-06-07 WO disclosed
US-7342017-B2 1,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety EURO-CELTIQUE S.A. (LU) 2008-03-11 US disclosed
EP-1487829-B1 THIADIAZOLYLPIPERAZINE DERIVATIVES USEFUL FOR TREATING OR PREVENTING PAIN EURO CELTIQUE SA (LU) 2007-10-10 EP disclosed
US-20060074090-A1 1,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety EURO-CELTIQUE S.A. 2006-04-06 US disclosed
EP-1487829-A1 THIADIAZOLYLPIPERAZINE DERIVATIVES USEFUL FOR TREATING OR PREVENTING PAIN Euro-Celtique S.A. (LU) 2004-12-22 EP disclosed
US-20040006091-A1 Therapeutic agents useful for treating or preventing pain PURDUE PHARMA L.P. 2004-01-08 US disclosed
WO-2003074520-A1 THIADIAZOLYLPIPERAZINE DERIVATIVES USEFUL FOR TREATING OR PREVENTING PAIN EURO-CELTIQUE, S.A. (LU) 2003-09-12 WO disclosed